These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38890744)

  • 81. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
    BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Evaluating the impact of the DREAMS partnership to reduce HIV incidence among adolescent girls and young women in four settings: a study protocol.
    Birdthistle I; Schaffnit SB; Kwaro D; Shahmanesh M; Ziraba A; Kabiru CW; Phillips-Howard P; Chimbindi N; Ondeng'e K; Gourlay A; Cowan FM; Hargreaves JR; Hensen B; Chiyaka T; Glynn JR; Floyd S
    BMC Public Health; 2018 Jul; 18(1):912. PubMed ID: 30045711
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.
    Murewanhema G; Malisheni M; Takah NF
    Pan Afr Med J; 2021; 38():308. PubMed ID: 34178226
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
    PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda.
    Nakalega R; Mukiza N; Menge R; Kizito S; Babirye JA; Kuteesa CN; Mawanda D; Mulumba E; Nabukeera J; Ggita J; Nakanjako L; Akello C; Mirembe BG; Lukyamuzi Z; Nakaye C; Kataike H; Maena J; Etima J; Nabunya HK; Biira F; Nagawa C; Heffron R; Celum C; Gandhi M; Mujugira A
    BMC Public Health; 2023 Jun; 23(1):1163. PubMed ID: 37322510
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.
    Springer SA; Nijhawan AE; Knight K; Kuo I; Di Paola A; Schlossberg E; Frank CA; Sanchez M; Pankow J; Proffitt RP; Lehman W; Pulitzer Z; Thompson K; Violette S; Harding KK;
    BMC Infect Dis; 2022 Apr; 22(1):380. PubMed ID: 35428213
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.
    Dunbar MS; Kripke K; Haberer J; Castor D; Dalal S; Mukoma W; Mullick S; Patel P; Reed J; Subedar H; Were D; Warren M; Torjesen K
    Sex Health; 2018 Nov; 15(6):513-521. PubMed ID: 30408431
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
    J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mystery Shopper Assessment of PrEP Service Delivery Quality for Adolescent Girls and Young Women in Kenya: A Cross-sectional Study.
    Kohler P; Larsen A; Sila J; Wilson K; Abuna F; Lagat H; Owiti G; Owens T; Pintye J; Richardson B; John-Stewart G; Kinuthia J
    J Assoc Nurses AIDS Care; 2022 Sep-Oct 01; 33(5):534-541. PubMed ID: 35878051
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Health care providers' attitudes toward and experiences delivering oral PrEP to adolescent girls and young women in Kenya, South Africa, and Zimbabwe.
    Lanham M; Ridgeway K; Mireku M; Nhamo D; Pillay D; Murire M; Stankevitz K; Kyongo J; Mullick S;
    BMC Health Serv Res; 2021 Oct; 21(1):1112. PubMed ID: 34663320
    [TBL] [Abstract][Full Text] [Related]  

  • 92. PrEP distribution in pharmacies: a systematic review.
    Kennedy CE; Yeh PT; Atkins K; Ferguson L; Baggaley R; Narasimhan M
    BMJ Open; 2022 Feb; 12(2):e054121. PubMed ID: 35190430
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mandrax use, sexual risk, and opportunities for pre-exposure prophylaxis among out-of-school adolescent girls and young women in Cape Town, South Africa.
    Bonner CP; Browne FA; Carney T; Shangase N; Ndirangu JW; Myers B; Wechsberg WM
    S Afr Med J; 2022 Apr; 112(5):341-346. PubMed ID: 35587247
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
    Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
    BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
    [TBL] [Abstract][Full Text] [Related]  

  • 95. HIV risk, risk perception, and PrEP interest among adolescent girls and young women in Lilongwe, Malawi: operationalizing the PrEP cascade.
    Hill LM; Maseko B; Chagomerana M; Hosseinipour MC; Bekker LG; Pettifor A; Rosenberg NE
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25502. PubMed ID: 32602649
    [TBL] [Abstract][Full Text] [Related]  

  • 96. HIV risk and pre-exposure prophylaxis interest among women seeking post-abortion care in Kenya: a cross-sectional study.
    Heffron R; Casmir E; Aswani L; Ngure K; Kwach B; Ogello V; Kiptinness C; Ambiyo F; Wairimu N; Ossome E; Machafu H; Zia Y; Thomas D; Scoville C; Barker T; Bukusi E; Mugo N
    J Int AIDS Soc; 2021 May; 24(5):e25703. PubMed ID: 33973355
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study.
    Beauchamp G; Hosek S; Donnell DJ; Chan KCG; Flaherty BP; Anderson PL; Dye BJ; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
    PLoS One; 2023; 18(2):e0281728. PubMed ID: 36827440
    [TBL] [Abstract][Full Text] [Related]  

  • 98. M
    Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
    Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Service delivery models that promote linkages to PrEP for adolescent girls and young women and men in sub-Saharan Africa: a scoping review.
    Ramraj T; Chirinda W; Jonas K; Govindasamy D; Jama N; McClinton Appollis T; Zani B; Mukumbang FC; Basera W; Hlongwa M; Turawa EB; Mathews C; Nicol E
    BMJ Open; 2023 Mar; 13(3):e061503. PubMed ID: 36972966
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.
    Nair G; Celum C; Szydlo D; Brown ER; Akello CA; Nakalega R; Macdonald P; Milan G; Palanee-Phillips T; Reddy K; Tahuringana E; Muhlanga F; Nakabiito C; Bekker LG; Siziba B; Hillier SL; Baeten JM; Garcia M; Johnson S; McClure T; Levy L; Livant E; Jacobson C; Soto-Torres L; van der Straten A; Hosek S; Rooney JF; Steytler J; Bunge K; Parikh U; Hendrix C; Anderson P; Ngure K;
    Lancet HIV; 2023 Dec; 10(12):e779-e789. PubMed ID: 37898146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.